Literature DB >> 29371338

Persistent Hematuria in ANCA Vasculitis: Ominous or Innocuous?

Shannon L Mahoney1, Patrick H Nachman2.   

Abstract

Entities:  

Keywords:  ANCA vasculitis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Hematuria; hematuria; relapse

Mesh：

Substances：

Year:  2018        PMID： 29371338      PMCID： PMC5967444          DOI： 10.2215/CJN.14101217

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

1.  Persistent or new onset microscopic hematuria in patients with small vessel vasculitis in remission: findings on renal biopsy.

Authors:  Duvuru Geetha; Philip Seo; Carla Ellis; Michael Kuperman; Stuart M Levine
Journal:  J Rheumatol       Date:  2012-06-01       Impact factor: 4.666

2.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

Review 3.  Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review.

Authors:  Rainer Birck; Wilhelm H Schmitt; Isabelle A Kaelsch; Fokko J van der Woude
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

4.  ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease.

Authors:  Michael J Kemna; Jan Damoiseaux; Jos Austen; Bjorn Winkens; Jim Peters; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2014-10-16       Impact factor: 10.121

5.  A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Authors:  David Jayne; Niels Rasmussen; Konrad Andrassy; Paul Bacon; Jan Willem Cohen Tervaert; Jolanta Dadoniené; Agneta Ekstrand; Gill Gaskin; Gina Gregorini; Kirsten de Groot; Wolfgang Gross; E Christiaan Hagen; Eduardo Mirapeix; Erna Pettersson; Carl Siegert; Alberto Sinico; Vladimir Tesar; Kerstin Westman; Charles Pusey
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

6.  The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.

Authors:  Rennie L Rhee; John C Davis; Linna Ding; Fernando C Fervenza; Gary S Hoffman; Cees G M Kallenberg; Carol A Langford; W Joseph McCune; Paul A Monach; Philip Seo; Robert Spiera; E William St Clair; Ulrich Specks; John H Stone; Peter A Merkel
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-25       Impact factor: 8.237

7.  Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

Authors:  Kirsten de Groot; Lorraine Harper; David R W Jayne; Luis Felipe Flores Suarez; Gina Gregorini; Wolfgang L Gross; Rashid Luqmani; Charles D Pusey; Niels Rasmussen; Renato A Sinico; Vladimir Tesar; Philippe Vanhille; Kerstin Westman; Caroline O S Savage
Journal:  Ann Intern Med       Date:  2009-05-19       Impact factor: 25.391

8.  Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts.

Authors:  Christian Pagnoux; Susan L Hogan; Hyunsook Chin; J Charles Jennette; Ronald J Falk; Loïc Guillevin; Patrick H Nachman
Journal:  Arthritis Rheum       Date:  2008-09

9.  Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse.

Authors:  Matthew David Morgan; Matthew Szeto; Michael Walsh; David Jayne; Kerstin Westman; Niels Rasmussen; Thomas F Hiemstra; Oliver Flossmann; Annelies Berden; Peter Höglund; Lorraine Harper
Journal:  Arthritis Res Ther       Date:  2017-06-07       Impact factor: 5.156
  9 in total
  4 in total

1.  The Impact of Serum Anti-neutrophil Cytoplasmic Antibody on Clinical Characteristics and Outcomes in Pediatric-Onset Systemic Lupus Erythematosus Patients.

Authors:  Chun-Chun Gau; Min-Hua Tseng; Chao-Yi Wu; Huang-Yu Yang; Jing-Long Huang
Journal:  Front Med (Lausanne)       Date:  2021-04-16

2.  Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria.

Authors:  Peng He; Yang Zha; Jing Liu; Hanmin Wang; Lijie He
Journal:  Front Med (Lausanne)       Date:  2021-12-02

3.  Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome.

Authors:  Xiaohan Huang; Liangliang Chen; Lan Lan; Pingping Ren; Anqi Ni; Yanhong Ma; Yaomin Wang; Yilin Zhu; Ying Xu; Jianghua Chen; Fei Han
Journal:  Front Immunol       Date:  2021-07-09       Impact factor: 7.561

4.  Microhematuria Enhances the Risks of Relapse and Renal Progression in Primary Membranous Nephropathy.

Authors:  Peng He; Xiaoyong Yu; Yang Zha; Jing Liu; Hanmin Wang; Chen Huang; Shiren Sun; Lijie He
Journal:  Front Med (Lausanne)       Date:  2021-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.